Home
About
Services
Partners
Client Portfolio
News
Contact
U.S. regulator to review recommendation on Fiat Chrysler’s Jeep complaint against Mahindra
January 23, 2020
U.S. regulator plans enforcement actions against former Wells Fargo executives: source
January 23, 2020
0
Blues health insurers put up $55 million to take on generic drug makers
Published by
Muller&Green
at
January 23, 2020
Categories
RSS
Tags
A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that aims to offer cheaper prices to their members on generic drugs that currently have little or no competition, the companies said on Thursday.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more